keyword
https://read.qxmd.com/read/35100527/depression-why-drugs-and-electricity-are-not-the-answer
#21
REVIEW
John Read, Joanna Moncrieff
The dominant view within mental health services and research suggests that feeling depressed is a kind of medical illness, partially caused by various biological deficits which are somehow corrected by physical interventions. This article critically appraises evidence for the effectiveness and value of antidepressant drugs and electroconvulsive therapy (ECT), the two principle physical treatments recommended for depression. It also describes the negative effects of these interventions and raises concerns about how they impact the brain...
June 2022: Psychological Medicine
https://read.qxmd.com/read/35048830/esketamine-uncertain-safety-and-efficacy-data-in-depression
#22
COMMENT
Mark Horowitz, Joanna Moncrieff
No abstract text is available yet for this article.
November 2021: British Journal of Psychiatry
https://read.qxmd.com/read/35048828/are-we-repeating-mistakes-of-the-past-a-review-of-the-evidence-for-esketamine-corrigendum
#23
JOURNAL ARTICLE
Mark A Horowitz, Joanna Moncrieff
No abstract text is available yet for this article.
November 2021: British Journal of Psychiatry
https://read.qxmd.com/read/34935541/-a-landmark-in-psychiatric-progress-the-role-of-evidence-in-the-rise-and-fall-of-insulin-coma-therapy
#24
JOURNAL ARTICLE
Robert Freudenthal, Joanna Moncrieff
This paper examines the evidence behind the use and decline of insulin coma therapy as a treatment for schizophrenia and how this was viewed by the psychiatric profession. The paper demonstrates that, from the time of its introduction, there was considerable debate regarding the evidence for insulin treatment, and scepticism about its purported benefits. The randomized trials conducted in the 1950s were the result, rather than the origins, of this debate. Although insulin treatment was subsequently abandoned, it was still regarded as a historic moment in the modernization of psychiatry...
March 2022: History of Psychiatry
https://read.qxmd.com/read/34845476/antidepressant-prescribing-in-general-practice-a-call-to-action
#25
JOURNAL ARTICLE
Katharine A Wallis, Maria Donald, Joanna Moncrieff
No abstract text is available yet for this article.
December 2021: Australian Journal of General Practice
https://read.qxmd.com/read/34844572/a-systematic-review-of-the-effects-of-psychiatric-medications-on-social-cognition
#26
JOURNAL ARTICLE
Zoë Haime, Andrew J Watson, Nadia Crellin, Louise Marston, Eileen Joyce, Joanna Moncrieff
INTRODUCTION: Social cognition is an important area of mental functioning relevant to psychiatric disorders and social functioning, that may be affected by psychiatric drug treatments. The aim of this review was to investigate the effects of medications with sedative properties, on social cognition. METHOD: This systematic review included experimental and neuroimaging studies investigating drug effects on social cognition. Data quality was assessed using a modified Downs and Black checklist (Trac et al...
November 29, 2021: BMC Psychiatry
https://read.qxmd.com/read/34556539/later-is-not-necessarily-better-limitations-of-survival-analysis-in-studies-of-long-term-drug-treatment-of-psychiatric-conditions
#27
JOURNAL ARTICLE
Joanna Moncrieff, Janus Christian Jakobsen, Max Bachmann
Survival analysis is routinely used to assess differences between groups in relapse prevention and treatment discontinuation studies involving people with long-term psychiatric conditions. The actual outcome in survival analysis is 'time to event', yet, in the mental health field, there has been little consideration of whether a temporary delay to relapse is clinically relevant in a condition that can last for decades. Moreover, in psychiatric drug trials, a pattern of elevated early relapses following randomisation to placebo or no treatment is common...
September 23, 2021: BMJ Evidence-Based Medicine
https://read.qxmd.com/read/34542027/tapering-antipsychotic-medication-practical-considerations
#28
JOURNAL ARTICLE
Mark A Horowitz, Joanna Moncrieff, Lieuwe de Haan, Jan P A M Bogers, Shiral S Gangadin, Martijn Kikkert, Wim Veling, Iris E C Sommer
No abstract text is available yet for this article.
September 20, 2021: Psychological Medicine
https://read.qxmd.com/read/34269688/a-digital-intervention-for-primary-care-practitioners-to-support-antidepressant-discontinuation-advisor-for-health-professionals-development-study
#29
JOURNAL ARTICLE
Hannah Bowers, Tony Kendrick, Nadja van Ginneken, Marta Glowacka, Samantha Williams, Geraldine M Leydon, Carl May, Christopher Dowrick, Joanna Moncrieff, Chris F Johnson, Michael Moore, Rebecca Laine, Adam W A Geraghty
BACKGROUND: The number of people receiving antidepressants has increased in the past 3 decades, mainly because of people staying on them longer. However, in many cases long-term treatment is not evidence based and risks increasing side effects. Additionally, prompting general practitioners (GPs) to review medication does not improve the rate of appropriate discontinuation. Therefore, GPs and other health professionals may need help to support patients discontinuing antidepressants in primary care...
July 16, 2021: Journal of Medical Internet Research
https://read.qxmd.com/read/34195470/how-do-participants-in-clinical-trials-compare-with-other-patients-with-schizophrenia
#30
JOURNAL ARTICLE
Robert Freudenthal, Louise Marston, Jacki L Stansfeld, Stefan Priebe, Joanna Moncrieff
We aimed to explore the clinical relevance of a multicentre, pragmatic randomised trial of antipsychotic reduction in people diagnosed with schizophrenia or psychosis The sample recruited for the antipsychotic reduction study (n = 69 people) was compared with the population of patients with an eligible diagnosis undergoing treatment in the same service (n = 3067 people), using routinely-collected, anonymised data. The trial sample was found to resemble the wider population in terms of the number of past admissions, the likelihood of having been subject to legal detention and the level of risk the patient was perceived to pose to themselves or others...
June 2021: Contemporary Clinical Trials Communications
https://read.qxmd.com/read/33267927/misleading-information-about-antipsychotics
#31
LETTER
Joanna Moncrieff
No abstract text is available yet for this article.
December 2020: Psychological Medicine
https://read.qxmd.com/read/32802967/the-social-underpinnings-of-mental-distress-in-the-time-of-covid-19-time-for-urgent-action
#32
JOURNAL ARTICLE
Nikolas Rose, Nick Manning, Richard Bentall, Kamaldeep Bhui, Rochelle Burgess, Sarah Carr, Flora Cornish, Delan Devakumar, Jennifer B Dowd, Stefan Ecks, Alison Faulkner, Alex Ruck Keene, James Kirkbride, Martin Knapp, Anne M Lovell, Paul Martin, Joanna Moncrieff, Hester Parr, Martyn Pickersgill, Genevra Richardson, Sally Sheard
We argue that predictions of a 'tsunami' of mental health problems as a consequence of the pandemic of coronavirus disease 2019 (COVID-19) and the lockdown are overstated; feelings of anxiety and sadness are entirely normal reactions to difficult circumstances, not symptoms of poor mental health.  Some people will need specialised mental health support, especially those already leading tough lives; we need immediate reversal of years of underfunding of community mental health services.  However, the disproportionate effects of COVID-19 on the most disadvantaged, especially BAME people placed at risk by their social and economic conditions, were entirely predictable...
2020: Wellcome Open Research
https://read.qxmd.com/read/32670542/barriers-to-stopping-neuroleptic-antipsychotic-treatment-in-people-with-schizophrenia-psychosis-or-bipolar-disorder
#33
REVIEW
Joanna Moncrieff, Swapnil Gupta, Mark Abie Horowitz
Most guidelines recommend long-term, indefinite neuroleptic (or antipsychotic) treatment for people with schizophrenia, recurrent psychosis or bipolar disorder, on the basis that these medications reduce the chance of relapse. However, neuroleptics have significant adverse effects, including sexual dysfunction, emotional blunting, metabolic disturbance and brain shrinkage, and patients often request to stop them. Evidence for the benefits of long-term treatment is also not as robust as generally thought. Short-term randomised trials show higher rates of relapse among those whose neuroleptic treatment is discontinued compared with those on maintenance treatment, but they are confounded by adverse effects associated with the withdrawal of established medication...
2020: Therapeutic Advances in Psychopharmacology
https://read.qxmd.com/read/32604796/muscle-cell-morphogenesis-structure-development-and-differentiation-processes-are-significantly-regulated-during-human-ovarian-granulosa-cells-in-vitro-cultivation
#34
JOURNAL ARTICLE
Claudia Dompe, Wiesława Kranc, Karol Jopek, Katarzyna Kowalska, Sylwia Ciesiółka, Błażej Chermuła, Artur Bryja, Maurycy Jankowski, Joanna Perek, Małgorzata Jozkowiak, Lisa Moncrieff, Greg Hutchings, Krzysztof Janowicz, Leszek Pawelczyk, Małgorzata Bruska, James Petitte, Paul Mozdziak, Magdalena Kulus, Hanna Piotrowska-Kempisty, Robert Z Spaczyński, Michał Nowicki, Bartosz Kempisty
Granulosa cells (GCs) have many functions and are fundamental for both folliculogenesis and oogenesis, releasing hormones and communicating directly with the oocyte. Long-term in vitro cultures of GCs show significant stem-like characteristics. In the current study, RNA of human ovarian granulosa cells was collected at 1, 7, 15 and 30 days of long-term in vitro culture. Understanding the process of differentiation of GCs towards different cell lineages, as well as the molecular pathways underlying these mechanisms, is fundamental to revealing other possible stemness markers of this type of cell...
June 26, 2020: Journal of Clinical Medicine
https://read.qxmd.com/read/32456714/are-we-repeating-mistakes-of-the-past-a-review-of-the-evidence-for-esketamine
#35
REVIEW
Mark A Horowitz, Joanna Moncrieff
Esketamine has been licensed for 'treatment-resistant depression' in the USA, UK and Europe. Licensing trials did not establish efficacy: two trials were negative, one showed a statistically significant but clinically uncertain effect, and a flawed discontinuation trial was included, against Food and Drug Administration precedent. Safety signals - deaths, including suicides, and bladder damage - were minimised.
November 2021: British Journal of Psychiatry
https://read.qxmd.com/read/32455542/human-cumulus-cells-in-long-term-in-vitro-culture-reflect-differential-expression-profile-of-genes-responsible-for-planned-cell-death-and-aging-a-study-of-new-molecular-markers
#36
JOURNAL ARTICLE
Błażej Chermuła, Wiesława Kranc, Karol Jopek, Joanna Budna-Tukan, Greg Hutchings, Claudia Dompe, Lisa Moncrieff, Krzysztof Janowicz, Małgorzata Józkowiak, Michal Jeseta, Jim Petitte, Paul Mozdziak, Leszek Pawelczyk, Robert Z Spaczyński, Bartosz Kempisty
In the ovarian follicle, maturation of the oocyte increases in the presence of somatic cells called cumulus cells (CCs). These cells form a direct barrier between the oocyte and external environment. Thanks to bidirectional communication, they have a direct impact on the oocyte, its quality and development potential. Understanding the genetic profile of CCs appears to be important in elucidating the physiology of oocytes. Long-term in vitro culture of CCs collected from patients undergoing controlled ovarian stimulation during in vitro fertilization procedure was conducted...
May 21, 2020: Cells
https://read.qxmd.com/read/32448374/reduce-reviewing-long-term-antidepressant-use-by-careful-monitoring-in-everyday-practice-internet-and-telephone-support-to-people-coming-off-long-term-antidepressants-protocol-for-a-randomised-controlled-trial
#37
JOURNAL ARTICLE
Tony Kendrick, Adam W A Geraghty, Hannah Bowers, Beth Stuart, Geraldine Leydon, Carl May, Guiqing Yao, Wendy O'Brien, Marta Glowacka, Simone Holley, Samantha Williams, Shihua Zhu, Rachel Dewar-Haggart, Bryan Palmer, Margaret Bell, Sue Collinson, Imogen Fry, Glyn Lewis, Gareth Griffiths, Simon Gilbody, Joanna Moncrieff, Michael Moore, Una Macleod, Paul Little, Christopher Dowrick
BACKGROUND: Around one in ten adults take antidepressants for depression in England, and their long-term use is increasing. Some need them to prevent relapse, but 30-50% could possibly stop them without relapsing and avoid adverse effects and complications of long-term use. However, stopping is not always easy due to withdrawal symptoms and a fear of relapse of depression. When general practitioners review patients on long-term antidepressants and recommend to those who are suitable to stop the medication, only 6-8% are able to stop...
May 24, 2020: Trials
https://read.qxmd.com/read/32152159/supporting-antidepressant-discontinuation-the-development-and-optimisation-of-a-digital-intervention-for-patients-in-uk-primary-care-using-a-theory-evidence-and-person-based-approach
#38
JOURNAL ARTICLE
Hannah M Bowers, Tony Kendrick, Marta Glowacka, Samantha Williams, Geraldine Leydon, Carl May, Chris Dowrick, Joanna Moncrieff, Rebecca Laine, Yvonne Nestoriuc, Gerhard Andersson, Adam W A Geraghty
OBJECTIVES: We aimed to develop a digital intervention to support antidepressant discontinuation in UK primary care that is scalable, accessible, safe and feasible. In this paper, we describe the development using a theory, evidence and person-based approach. DESIGN: Intervention development using a theory, evidence and person-based approach. SETTING: Primary Care in the South of England. PARTICIPANTS: Fifteen participants with a range of antidepressant experience took part in 'think aloud' interviews for intervention optimisation...
March 8, 2020: BMJ Open
https://read.qxmd.com/read/31937376/the-functions-of-an-asylum-an-analysis-of-male-and-female-admissions-to-essex-county-asylum-in-1904
#39
JOURNAL ARTICLE
Joseph Rehling, Joanna Moncrieff
BACKGROUND: Contrasting historical views represent the asylum as a manifestation of humanitarian and therapeutic progress or as an institution of social control designed to bolster the capitalist economic order. More extreme critics suggest it was used to incarcerate people exhibiting only political or social deviance. METHODS: Case notes of 200 consecutive male and female admissions to the Essex County Asylum in 1904 were inspected. The nature of presentations was classified in contemporary terms into broad categories of disorder...
January 15, 2020: Psychological Medicine
https://read.qxmd.com/read/31875238/experiences-of-taking-neuroleptic-medication-and-impacts-on-symptoms-sense-of-self-and-agency-a-systematic-review-and-thematic-synthesis-of-qualitative-data
#40
JOURNAL ARTICLE
Jemima Thompson, Jacki L Stansfeld, Ruth E Cooper, Nicola Morant, Nadia E Crellin, Joanna Moncrieff
PURPOSE: Neuroleptic (antipsychotic) drugs reduce psychotic symptoms, but how they achieve these effects and how the drugs' effects are experienced by people who take them are less well understood. The present study describes a synthesis of qualitative data about mental and behavioural alterations associated with taking neuroleptics and how these interact with symptoms of psychosis and people's sense of self and agency. METHODS: Nine databases were searched to identify qualitative literature concerning experiences of taking neuroleptic medication...
February 2020: Social Psychiatry and Psychiatric Epidemiology
keyword
keyword
25127
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.